Home | Infections | Hepatitis


New Treatments Tame Hepatitis C Virus, Lessen Side Effects Seen with Other Therapies

PHILADELPHIA — Three million Americans suffer from Hepatitis C Virus (HCV) infection, with baby boomers representing a large proportion of those infected. ...

Deaths from viral hepatitis surpasses HIV/AIDS as a preventable cause of deaths in Australia

Deaths from viral Hepatitis B and C have surpassed HIV/AIDS in many countries, including Australia and in Western Europe, according to an ...

Breaking Bad Mitochondria

Mechanism helps explain persistence of hepatitis C virus ... Full story

Breakthrough treatment for hepatitis C

A breakthrough treatment for hepatitis C that halves treatment time has been developed in an international clinical trial that included The University of Queensland. ... Full story

WHO issues its first hepatitis C treatment guidelines

London, United Kingdom - WHO has issued its first guidance for the treatment of hepatitis C, a chronic infection that affects an estimated 130 million to 150 million people and results in 350 000 to 500 000 deaths a year. ... Full story

Small cash incentives improve hep B vaccination rates among injecting drug users

Small financial incentives, totalling as little as £30, can dramatically increase the likelihood of people who inject drugs completing a course of hepatitis B virus (HBV) vaccination, according to new research led by King's College London, published today in The Lancet. ... Full story

Gene variants protect against relapse after treatment for Hepatitis C

Researchers at the Sahlgrenska Academy have identified a gene, which explains why certain patients with chronic hepatitis C do not experience relapse after treatment. The discovery may contribute to more effective treatment. ... Full story

New hepatitis C drugs offer hope for effective treatment, fewer side effects

DALLAS – Patrizia Cazzaniga had heard the horror stories about early treatments for hepatitis C – multiple daily pills and weekly shots for up to a year, side effects that could be debilitating, and a cure rate of only about 40 percent. ... Full story

Hepatitis C prevalence in prisons lower than previously estimated

Correctional populations bear a declining yet sizable number of cases in the hepatitis C epidemic, according to Emory researchers at the Rollins School of Public Health. Nationally, 17.4 percent of all prisoners have been exposed to the hepatitis C virus. ... Full story

Can Low-Dose Interferon Prevent Relapse of Hepatitis C Virus Infection?

New Rochelle, NY —Chronic hepatitis C virus (HCV) infection can lead to serious diseases such as cirrhosis and cancer of the liver, so viral clearance and prevention of relapse are important treatment goals. Low-dose oral interferon may reduce the risk of HCV relapse in patients with mild liver fibrosis according to a study published in Journal of Interferon & Cytokine Research, a peer-reviewed publication from Mary Ann Liebert, Inc., publishers. The article is available free on the Journal of Interferon & Cytokine Research website. ... Full story

1 2 3 next total: 26 | displaying: 1 - 10